Employees: 1-10
Portfolio 15
| Date | Name | Website | Total Raised | Location |
| 19.11.2010 | MooBella, ... | moobella.com | $27M | - |
| - | MSI | methylationsciences.com | $48.37M | United Kin... |
| - | atonomics | atonomics.com | - | - |
| - | accera | accerapharma.com | - | - |
| - | opsona | opsona.com | $47.29M | Ireland, D... |
| - | Shield The... | shieldtherapeutics.com | $11.86M | United Kin... |
| - | Phagenesis... | phagenesis.com | $113.39M | United Sta... |
| - | Steaz | steaz.com | - | - |
| - | Velle | velleoats.com | - | Russia |
| - | gc-rise | gc-rise.com | $15M | - |
Show more
Mentions in press and media 12
| Date | Title | Description |
| 14.03.2018 | Nestlé Backs New European AgriFood Tech VC Five Seasons Ventures, Launching with €60m Fund | Five Seasons Ventures, a new European VC focusing on agrifood tech investments has launched its first fund, announcing a first close on €60 million ($74.3m). Backers include Nestlé, the European Investment Fund, Fondo Italiano d’Investiment... |
| 06.12.2016 | Tyson Joins List of Food Companies with Venture Capital Funds | This week, Tyson Foods joined the growing list of food companies with venture capital funds investing in food and agritech startups. The company, which earlier this year shocked the sector by making an investment in plant-based meat alterna... |
| 19.10.2016 | First summit for Female Founders | |
| 11.08.2016 | Steaz sold to 'privately-held strategic buyer' for undisclosed sum | Steaz is “the fastest growing RTD iced tea in the natural and organic category,” according to a press release issued by venture capital fund Inventages Wealth Management, which took a majority stake in Steaz in 2008. According to First B... |
| 16.07.2013 | One to watch: Medical device company says eye test can diagnose Alzheimer’s | PET imaging is approved to detect these kinds of plaques in living patients, but a noninvasive, low-cost option is needed, said Dr. Carl Sadowsky, the Medical Director at Premiere Research Institute in West Palm Beach, Fla., and a principal... |
| 05.03.2012 | Phosphate Therapeutics Raises up to €10.5M in Funding from Inventages Venture Capital | Phosphate Therapeutics, a UK-based independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, has raised up to €10.5m in funding from Inventages Venture Capital. The company intends ... |
| 04.10.2011 | Phagenesis Closes €7M Series B Funding Round | Phagenesis Ltd, a Manchester, UK-based company that is developing a treatment for acute and chronic dysphagia (inability to swallow safely), has closed a €7m Series B funding round. The round was led by Inventages, with existing shareholder... |
| 29.09.2011 | MSI Methylation Sciences Raises €13.5M in Series A Financing | MSI Methylation Sciences, Inc., a Vancouver, British Columbia Canada-based company focused on developing S-Adenosyl Methionine (SAMe), a prescription drug used as a dietary supplement, has raised €13.5m (CDN$19m) in a Series A financing. Th... |
| 19.11.2010 | MooBella Raises $9M from Inventages | MooBella, Inc., a Taunton, MA-based developer and supplier of a creamery machine’s multi-patented technology that allows consumers to make their own ice cream in less than a minute, has secured $9m in funding from Geneva-based Inventages. T... |
| 09.04.2009 | Investors give up on diabetes drug maker DiObex | After failing to raise a sustaining round of capital, DiObex has been effectively shut down by its investors. They have laid off the San Francisco company’s eight employees and are moving to quickly sell off its assets, including its lead d... |
Show more